MedTrace Logo

National Tunisian Clinical Registry on CardioVascular Secondary Prevention Clinical

NCT07034274 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 7284

Last updated 2026-05-11

No results posted yet for this study

Summary

A non-interventional, national longitudinal multicenter study of CV secondary prevention in Tunisia

Conditions

  • Secondary Prevention
  • CHD
  • CV Risk

Sponsors & Collaborators

  • Tunisian Society of Cardiology and Cardiovascular Surgery

    collaborator OTHER

  • Dacima Consulting

    lead OTHER

Principal Investigators

  • Youssef Ben Ameur, MD · Tunisian Society of Cardiology and Cardiovascular Surgery

  • Salma Charfeddine, MD · Tunisian Society of Cardiology and Cardiovascular Surgery

  • Ihsen Zairi, MD · Tunisian Society of Cardiology and Cardiovascular Surgery

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-06-09
Primary Completion
2025-07-31
Completion
2025-07-31

Countries

  • Tunisia

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07034274 on ClinicalTrials.gov